Ireland
--:--IST
Recruiting Not applicable

Efficacy of Video-Based Interactive Game Therapy in Interstitial Lung Patients

NCT06087692 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2023-01-01
Last updated
2024-11-19

Condition(s) studied

Interstitial Lung Disease

Investigational drug(s) / intervention(s)

Exercise

Exercise: -based game therapy applied in addition to aerobic exercise

Study summary

Interstitial lung disease (ILD) is a heterogeneous group of diseases consisting of variable amounts of inflammation and fibrosis and a wide variety of acute and chronic pulmonary disorders affecting both the interstitium and lung parenchyma. The use of gamification elements in order to encourage changes in health behaviors such as physical activity appears as an entertaining option by increasing extrinsic motivation in sedentary individuals or in diseases where physical activity is targeted. The aim of this study is to investigate the effectiveness of Nintendo Wii applied in addition to aerobic exercise in patients with ILD on exercise capacity and peripheral muscle strength, symptoms, activity and participation with objective methods, based on evidence.

Eligibility

Sex
ALL
Min age
40 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Diagnosed with ILD (Interstitial lung disease) by a chest diseases specialist, aged between 40-65 years, and have been under follow-up for at least 6 months according to the current ATS/ERS guidelines. * Clinically stable, with no exacerbations or infections. * Able to walk, with no visual or auditory impairments. * Patients with cognitive abilities sufficient to understand commands. Exclusion Criteria: Orthopedic and neurological problems that could hinder exercise training. * Changes in medical treatment during the study. * Unstable cardiac diseases. * Insufficient cooperation. * Diagnosed visual, auditory, vestibular, or neurological problems that could affect balance.

Primary outcome measure(s)

  • 6 minute walk test — through study completion, an average of 1 year
    6 minute walk test:Used to determine submaximal functional exercise capacity. Patients are asked to walk as far as possible in a 30-meter straight corridor at their own walking pace for six minutes. The patient rests in a sitting position for 10 minutes in the corridor before starting the test. Oxygen saturation, heart rate, blood pressure, dyspnea, and leg fatigue scores are recorded before and after the test. The distance walked in six minutes is recorded.
  • Incremental Shuttle Walk Test — through study completion, an average of 1 year
    Incremental Shuttle Walk Test (ISWT): Used to determine functional exercise capacity. Patients walk around a cassette with signals previously recorded at a rate of 0.17 m/s, which increases every minute, starting at a pace of 10 meters per minute. The test consists of a maximum of 12 stages. The test is terminated if the patient cannot complete it within the allowed time (if the patient is more than 0.5 meters away from the signal cone when the signal sounds) or if the patient reaches 85% of the predicted maximum heart rate calculated according to the formula \[210 - (0.65 x age)\]. Oxygen saturation, heart rate, blood pressure, dyspnea, and leg fatigue scores are recorded before and after the test. The walking distance is recorded.
  • Endurance Shuttle Walk Test — through study completion, an average of 1 year
    Endurance Shuttle Walk Test (ESWT): Endurance capacity is determined using ESWT. The walking speed (workload) to be used in ESWT will be calculated as 85% of the maximum sustainable speed obtained from ISWT. Patients are asked to warm up by walking at a slower pace for two minutes and then to walk at a steady pace. The test is terminated if the patient feels too breathless to continue walking, becomes fatigued, or completes the 20-minute test duration. Oxygen saturation, heart rate, blood pressure, dyspnea, and leg fatigue scores are recorded before and after the test. The walking time is recorded in seconds.

Trial sites (1)

FacilityCityRegionStatus
İstanbul Faculty of Medicine Istanbul Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06087692 on ClinicalTrials.gov ↗ ← All trials in Turkey